Beam Therapeutics to Participate in the 43rd Annual Cowen Healthcare Conference
01.03.2023 - CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) - Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will ...
Source: wallstreet-online.de